Alcohol dependence
Conditions
Interventions
Prior administered group: patients administered control drug (vitamin C, product name: Cinal, 600mg/day) during 3 months after ifenprodil (product name: Cerocral, 60mg/day) during 3 months
Latter ad
Sponsors
Tokyo Metropolitan Institute of Medical Science
Tokyo Metropolitan Matsuzawa Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Outpatients diagnosed as alcohol dependence 2) Stabilized patients who can complete the questionnaire 3) Patients in abstinence within 2 years 4) Patients who can respond in Japanese 5) Patients suspected mild cognitive deficiency from the results of a test of cognitive functions (or existing brain image data)
Exclusion criteria
Exclusion criteria: 1) Patients with noncompliance 2) Participants of other clinical trials 3) Patients with comorbid psychiatric disorder (e.g. schizophrenia) or serious physical diseases 4) Patients with considerably low motivation for treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Slip: alcohol use during the past month 2) Level of alcohol drinking: frequency and amount of alcohol drinking 3) Dropout: dropout of treatment 4) Craving and relapse risk: assessment by self-rating questionnaire including VAS and Alcohol Relapse Risk Scale (ARRS) | — |
Countries
Japan
Contacts
Public ContactYasukazu Ogai
Tokyo Metropolitan Institute of Medical Science Addictive Substance Project
Outcome results
None listed